de Lucena, L. A., Cavalcante, D. V. S., Montenegro, M. V., Hespanhol, L. C., de Oliveira, W. S., Muniz, J. Q., … Giorgi, J. (2026). Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes. Curr Diab Rep, 26(1). https://doi.org/10.1007/s11892-026-01622-9

Lucena, Larissa Araújo de, Deivyd V. S. Cavalcante, Marcela V. Montenegro, Larissa C. Hespanhol, William S. de Oliveira, Juliana Q. Muniz, Sruti Prathivadhi-Bhayankaram, Edgardo Kaplinsky, Alejandro Barbagelata, and Juliana Giorgi. “Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes.” Curr Diab Rep 26, no. 1 (April 10, 2026). https://doi.org/10.1007/s11892-026-01622-9.

de Lucena LA, Cavalcante DVS, Montenegro MV, Hespanhol LC, de Oliveira WS, Muniz JQ, et al. Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes. Curr Diab Rep. 2026 Apr 10;26(1).

de Lucena, Larissa Araújo, et al. “Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes.” Curr Diab Rep, vol. 26, no. 1, Apr. 2026. Pubmed, doi:10.1007/s11892-026-01622-9.

de Lucena LA, Cavalcante DVS, Montenegro MV, Hespanhol LC, de Oliveira WS, Muniz JQ, Prathivadhi-Bhayankaram S, Kaplinsky E, Barbagelata A, Giorgi J. Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes. Curr Diab Rep. 2026 Apr 10;26(1).